Eliquis Side Effects: Bleeding Risks and What to Watch For

Eliquis Side Effects: Bleeding Risks and What to Watch For
Key takeaways
  • Eliquis (apixaban) is a Factor Xa inhibitor blood thinner, and its main risk is bleeding — from minor bruising to rare but life-threatening hemorrhage.
  • Call 911 for severe bleeding warning signs: black or bloody stools, vomiting blood or "coffee-ground" material, coughing up blood, a sudden severe headache, one-sided weakness, or bleeding you cannot control.
  • Never stop Eliquis on your own — stopping without a doctor's guidance raises your risk of stroke and dangerous clots (this is an FDA boxed warning).
  • Unlike warfarin, Eliquis has NO vitamin-K diet restriction — you do not need to limit leafy greens; keep your normal diet unless your doctor says otherwise.
  • A reversal agent (andexanet alfa) exists for emergency bleeding, but it is hospital-only; Eliquis also carries a boxed warning about spinal/epidural hematoma with neuraxial procedures.
  • Avoid NSAIDs and other blood thinners unless your prescriber approves, tell every provider you take Eliquis, and let your doctor decide all dosing.

Eliquis (apixaban) is one of the most widely prescribed blood thinners in the United States, used for atrial fibrillation and for treating and preventing blood clots. Its popularity stems from fewer dietary restrictions and less routine blood-test monitoring compared with warfarin — but that convenience does not mean it is without risk. The most important Eliquis side effects revolve around bleeding, from minor bruising to rare but potentially life-threatening hemorrhage. Every patient on this medication needs to understand where that line falls, and — just as important — why you should never stop it on your own. This article is educational and does not include a dosing schedule; how much Eliquis you take is a decision for your prescriber.

How Eliquis Works as a Blood Thinner

Eliquis is a direct oral anticoagulant (DOAC) that works by selectively inhibiting Factor Xa, a key enzyme in the blood-clotting cascade. By blocking Factor Xa, apixaban reduces the formation of thrombin and, ultimately, fibrin clots. According to MedlinePlus, apixaban is used to reduce the risk of stroke and blood clots in people with non-valvular atrial fibrillation, to treat deep vein thrombosis (DVT) and pulmonary embolism (PE), and to prevent clots after hip or knee replacement surgery.

Unlike warfarin, Eliquis does not require regular INR blood tests and has far fewer food interactions. However, its anticoagulant effect is not routinely measured through standard lab work, which is both an advantage (less monitoring) and a limitation (harder to gauge quickly in an emergency).

Stay ahead in healthcareThe latest happenings in the medical field — free, about monthly, no spam.

Common Eliquis Side Effects

The following Eliquis side effects are among those reported in clinical trials, particularly the landmark ARISTOTLE (atrial fibrillation) and AMPLIFY (venous thromboembolism) studies. The exact percentages differ between sources and patient populations, so treat any specific figure as an approximation to verify:

  • Minor bleeding — bruising, nosebleeds, gum bleeding, and small cuts that bleed longer than usual; this is the most common effect
  • Nausea
  • Anemia — a decrease in hemoglobin, sometimes from occult (hidden) bleeding
  • Rash and other mild skin reactions
  • Mild, often symptom-free elevations in liver enzymes

Minor bleeding events are expected consequences of any anticoagulant. Many patients learn to manage them — using a soft toothbrush, an electric razor, and being careful with sharp objects. A nosebleed that stops within about 10-15 minutes with steady pressure is generally not alarming. However, frequent, heavy, or prolonged minor bleeding should be reported to your doctor.

Serious Bleeding Risks — Know the Emergency Signs

Major bleeding is the most significant risk with Eliquis and the side effect that carries the greatest consequences. In the ARISTOTLE trial, apixaban caused less major bleeding than warfarin, which is a meaningful advantage — but the absolute risk is not zero, and serious bleeding can be an emergency.

Types of Serious Bleeding

  • Gastrointestinal bleeding — signs include black, tarry, or bloody stools; vomiting blood or material that looks like coffee grounds; or severe abdominal pain
  • Intracranial hemorrhage (bleeding in the brain) — signs include a sudden severe headache, confusion, vision changes, and weakness or numbness on one side of the body
  • Urinary-tract bleeding — pink, red, or brown urine
  • Retroperitoneal or other internal bleeding — rare but serious; may cause severe back or abdominal pain, dizziness, or fainting

When to call 911: Get emergency help right away for bleeding you cannot control; black, red, or bloody stools; vomiting blood or “coffee-ground” material; coughing up blood; a sudden, severe headache; sudden numbness, weakness, confusion, or trouble speaking; or any fall or blow to the head. On a blood thinner, a head injury can cause dangerous bleeding even when you feel fine at first, so it should always be evaluated.

The FDA has approved andexanet alfa (Andexxa) as a reversal agent for life-threatening or uncontrolled bleeding on apixaban or rivaroxaban. Knowing a reversal agent exists can be reassuring, but it is available only in hospital settings, is used in specific emergencies, and is not something you can access at home.

The Vitamin-K Myth: Eliquis Is NOT Like Warfarin on Diet

This is one of the most common points of confusion, so it is worth stating plainly: Eliquis does not require a vitamin-K or leafy-green diet restriction. The advice to keep vitamin-K intake (spinach, kale, broccoli, and other greens) consistent applies to warfarin, which works by interfering with vitamin-K-dependent clotting factors. Eliquis works differently — it directly blocks Factor Xa — so vitamin K does not counteract it in the same way.

MedlinePlus advises that, unless your doctor tells you otherwise, you should continue your normal diet while taking apixaban. You do not need to avoid or “balance” green vegetables. If you have been avoiding healthy foods because you confused Eliquis with warfarin, this is worth raising with your prescriber or pharmacist.

Drug Interactions That Increase Risk

Eliquis is processed by the CYP3A4 enzyme and the P-glycoprotein (P-gp) transport system. Medications that strongly affect these systems can raise or lower Eliquis levels. Because these interactions can change how well the drug protects you — or how much it raises bleeding risk — your prescriber, not an article, should make any adjustment.

  • Strong CYP3A4 and P-gp inhibitors — such as certain antifungals (ketoconazole, itraconazole) and some antivirals (for example, ritonavir) can increase Eliquis levels and bleeding risk
  • Strong CYP3A4 and P-gp inducers — such as rifampin, carbamazepine, phenytoin, and St. John’s wort can lower Eliquis levels and may reduce its protection against clots
  • Other anticoagulants and antiplatelet drugs — aspirin, clopidogrel, heparin, and other blood thinners substantially increase bleeding risk when combined with Eliquis
  • NSAIDs — ibuprofen, naproxen, and other NSAIDs raise both bleeding and stomach-ulcer risk; ask before using them
  • SSRIs and SNRIs — antidepressants such as duloxetine can affect platelet function and may modestly add to bleeding risk

Always tell every healthcare provider and pharmacist that you take Eliquis — including dentists, urgent care clinicians, and surgeons. The medication may need to be paused before certain procedures, and the timing depends on the procedure and your kidney function. Visit our medical conditions guide for more on managing anticoagulant therapy.

Never Stop Eliquis on Your Own — The Boxed Warnings

Eliquis carries two FDA boxed warnings (the agency’s most serious label warning), and both are important to understand.

1. Stopping the drug increases the risk of stroke and clots. MedlinePlus and the FDA prescribing information warn that discontinuing apixaban prematurely — without adequate alternative anticoagulation — raises the risk of blood clots and stroke, especially in people with atrial fibrillation. This is why you should never stop Eliquis on your own, skip doses to “give your body a break,” or run out because of a refill delay. If cost, side effects, or an upcoming procedure make you want to stop, call your prescriber first so a safe plan can be made.

2. Spinal/epidural hematoma with neuraxial procedures. If you receive spinal or epidural anesthesia or a spinal puncture while on Eliquis, blood can collect around the spinal cord and, rarely, cause long-lasting or permanent paralysis. Anyone planning such a procedure must tell the anesthesia and surgical team well in advance that they take Eliquis.

If you do need to pause Eliquis for surgery, your doctor will tell you exactly when to take the last dose and when to restart. Bridging with injectable heparin is rarely needed with DOACs, unlike with warfarin — but that, too, is a clinical decision, not something to manage yourself.

Side Effects in Specific Populations

Older Adults

Bleeding risk generally rises with age. In older patients, prescribers weigh factors such as age, body weight, and kidney function (measured by serum creatinine) when choosing a dose. Whether a lower dose is appropriate is a decision your clinician makes — this article intentionally does not provide dose numbers. Proper individualized dosing is intended to lower bleeding risk while preserving stroke protection.

Kidney Impairment

Some apixaban is cleared by the kidneys, so reduced kidney function can affect the drug. Eliquis is often considered in kidney disease when other DOACs are less suitable, but severe renal impairment and dialysis are complex situations with more limited data. Periodic kidney-function checks are important during long-term therapy.

Cancer Patients

People with active cancer face elevated risks of both clotting and bleeding. Eliquis is increasingly used for cancer-associated venous thromboembolism, supported by trials such as CARAVAGGIO, which found efficacy comparable to low-molecular-weight heparin with acceptable bleeding rates. However, some gastrointestinal cancers may raise bleeding risk, so the choice is individualized.

When to Call Your Doctor

Contact your healthcare provider (and seek emergency care for the severe signs above) if you notice:

  • Frequent nosebleeds or gum bleeding that seems to be increasing
  • Heavy menstrual periods or unexpected vaginal bleeding
  • Pink, red, or dark brown urine
  • Red, black, or tarry stools
  • Unusual bruising that is larger or more frequent than normal
  • Persistent headache, dizziness, or unusual fatigue (which can signal slow blood loss)
  • Joint pain and swelling (a possible bleed into a joint)
  • Any planned dental work or surgery — tell providers well in advance

Frequently Asked Questions

Can I eat green vegetables while taking Eliquis?

Yes. Unlike warfarin, Eliquis is not affected by vitamin K, so you do not need to limit leafy greens. MedlinePlus advises continuing your normal diet unless your doctor says otherwise. This is one of the practical advantages of Eliquis over warfarin.

Can I just stop Eliquis if I’m worried about bleeding?

No — do not stop on your own. Stopping Eliquis without medical guidance raises your risk of stroke and dangerous clots, which is why it carries an FDA boxed warning. If you are worried about bleeding, cost, or an upcoming procedure, call your prescriber to make a safe plan.

Does Eliquis cause fatigue?

Fatigue is not a common direct side effect. However, if Eliquis is causing slow, hidden blood loss, the resulting anemia can cause fatigue and weakness. If you feel unusually tired, tell your doctor, who may check your blood count.

What happens if I miss a dose of Eliquis?

General guidance is to take a missed dose the same day and then resume your regular schedule, without doubling up. But because instructions can depend on your situation, follow the directions from your prescriber or pharmacist, and ask them if you are unsure. Consistent dosing matters because Eliquis has a relatively short duration of action.

Is Eliquis safer than warfarin?

For many patients with non-valvular atrial fibrillation, trials show Eliquis causes fewer major bleeds and fewer strokes than warfarin, including a lower rate of bleeding in the brain. However, warfarin remains preferred for certain conditions, such as mechanical heart valves. Your doctor can determine which is best for you.

Practical Takeaways on Eliquis Side Effects

Living safely on Eliquis means understanding that some minor bleeding is expected, learning to recognize the warning signs of serious hemorrhage, and never adjusting or stopping the drug on your own. Eliquis side effects are dominated by bleeding, but for most patients the drug’s clinical profile compares favorably with warfarin. Avoid NSAIDs unless approved, report any new medications and supplements, keep your normal diet (no vitamin-K restriction), and make sure every provider you see knows you take an anticoagulant. Carrying identification that notes you take a blood thinner is a smart precaution.

Medical disclaimer: This article is general education, not medical advice, and it intentionally does not provide dosing instructions. Eliquis (apixaban) is a prescription anticoagulant that must be dosed and monitored by a licensed clinician. Do not start, stop, or change your dose on your own — stopping without medical guidance raises your risk of stroke and clots (an FDA boxed warning). Unlike warfarin, Eliquis has no vitamin-K diet restriction. For severe bleeding — black or bloody stools, vomiting blood, coughing up blood, a sudden severe headache, one-sided weakness, or a head injury — call 911. For other concerns, contact your prescriber or pharmacist.

Sources

  • MedlinePlus (U.S. National Library of Medicine) — Apixaban: uses, boxed warnings, bleeding signs, “continue your normal diet,” and interactions with NSAIDs, aspirin, and other blood thinners.
  • U.S. Food and Drug Administration (FDA) / DailyMed — ELIQUIS (apixaban) prescribing information: boxed warnings for discontinuation risk and spinal/epidural hematoma; CYP3A4/P-gp interactions.
  • FDA — andexanet alfa (Andexxa) approval as a reversal agent for apixaban and rivaroxaban.
  • Landmark clinical trials cited for context: ARISTOTLE, AMPLIFY, and CARAVAGGIO (exact percentages vary by source; verify current).